| Christina Strauch, SE | |
|
1246 Yellowstone Ave Ste C5, Pocatello, ID 83201-4373 | |
| (208) 233-0150 | |
| (208) 233-0159 |
| Full Name | Christina Strauch |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 1246 Yellowstone Ave Ste C5, Pocatello, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003583659 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | SE-202910 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Christina Strauch, SE 1246 Yellowstone Ave Ste C5, Pocatello, ID 83201-4373 Ph: (208) 233-0150 | Christina Strauch, SE 1246 Yellowstone Ave Ste C5, Pocatello, ID 83201-4373 Ph: (208) 233-0150 |
News Archive
Although reduced physical activity during the day is widely seen as a harbinger of mortality in older people, fragmentation of physical activity-;spreading daily activity across more episodes of brief activity-;may be an earlier indicator of mortality risk than total amount of daily activity, according to a new study from scientists at the Johns Hopkins Bloomberg School of Public Health.
Amorcyte, LLC, a NeoStem, Inc. company today announces the enrollment of the first patient in the Amorcyte PreSERVE Phase 2 trial for acute myocardial infarction.
A new study from ICES, Lawson Health Research Institute and Western University suggests that injection drug users prescribed controlled-release hydromorphone are three times more likely to develop endocarditis, a serious bacterial heart infection, when compared to those prescribed other opioids.
In a 10-year study of women who received radiation therapy to treat early-stage breast cancer, those receiving fewer, larger individual doses experienced similarly low rates of late-onset side effects as those undergoing conventional radiation therapy. Findings from the multi-institutional U.K. FAST clinical trial were presented last week at the 60th Annual Meeting of the American Society for Radiation Oncology.
Results from the PROfound phase III study, funded by AstraZeneca and Merck Sharp & Dohme, open up a much-needed new treatment avenue for the more precise and effective treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) whose disease has progressed with hormonal therapy.
› Verified 7 days ago
Ms. Dedra Christine Sanna, LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 409 Washington Ave, Pocatello, ID 83201 Phone: 208-234-2646 Fax: 208-232-0035 | |
Courtney Moore, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2055 Garrett Way, Ste 2, Pocatello, ID 83201 Phone: 208-233-7832 | |
Ms. Rit Larae Nauman, LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 3330 Highway 30 W, Pocatello, ID 83201 Phone: 208-234-9100 Fax: 208-234-9104 | |
Michael L Stevens, LCSW Counselor Medicare: Accepting Medicare Assignments Practice Location: 109 N Arthur Ave Ste 203, Pocatello, ID 83204 Phone: 208-234-4673 Fax: 208-234-4677 | |
Mrs. Cassidy Michelle Roske, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 409 Washington Ave, Pocatello, ID 83201 Phone: 208-234-2646 Fax: 208-232-0035 | |
Matthew R Christensen, LCSW Counselor Medicare: Medicare Enrolled Practice Location: 5230 W Moonlight Mine Rd., Pocatello, ID 83201 Phone: 208-351-3956 |